GSA Capital Partners LLP Lowers Holdings in Innospec Inc. $IOSP

GSA Capital Partners LLP trimmed its position in Innospec Inc. (NASDAQ:IOSP) by 38.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 17,422 shares of the specialty chemicals company’s stock after selling 10,852 shares during the period. GSA Capital Partners LLP owned approximately 0.07% of Innospec worth $1,333,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of IOSP. EverSource Wealth Advisors LLC grew its position in Innospec by 1,159.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock valued at $44,000 after buying an additional 487 shares during the last quarter. Allworth Financial LP grew its position in Innospec by 31.0% in the 3rd quarter. Allworth Financial LP now owns 588 shares of the specialty chemicals company’s stock valued at $45,000 after buying an additional 139 shares during the last quarter. Danske Bank A S purchased a new position in Innospec in the 3rd quarter valued at $46,000. State of Wyoming grew its position in Innospec by 27.5% in the 2nd quarter. State of Wyoming now owns 801 shares of the specialty chemicals company’s stock valued at $67,000 after buying an additional 173 shares during the last quarter. Finally, Signaturefd LLC grew its position in Innospec by 65.5% in the 4th quarter. Signaturefd LLC now owns 993 shares of the specialty chemicals company’s stock valued at $76,000 after buying an additional 393 shares during the last quarter. 96.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

IOSP has been the topic of a number of analyst reports. Weiss Ratings lowered shares of Innospec from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Monday, May 11th. Zacks Research upgraded shares of Innospec from a “strong sell” rating to a “hold” rating in a research report on Friday, April 24th. Finally, Wall Street Zen lowered shares of Innospec from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. One research analyst has rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce”.

Innospec Stock Performance

Shares of NASDAQ IOSP opened at $78.66 on Thursday. The firm has a market capitalization of $1.94 billion, a P/E ratio of 17.14, a PEG ratio of 2.14 and a beta of 0.90. Innospec Inc. has a one year low of $65.51 and a one year high of $92.14. The company’s fifty day moving average is $74.32 and its two-hundred day moving average is $76.87.

Innospec (NASDAQ:IOSP) last issued its earnings results on Friday, May 8th. The specialty chemicals company reported $1.05 EPS for the quarter, topping the consensus estimate of $1.02 by $0.03. The company had revenue of $453.20 million for the quarter, compared to analyst estimates of $432.14 million. Innospec had a net margin of 6.38% and a return on equity of 9.32%. The business’s revenue was up 2.8% on a year-over-year basis. During the same period in the previous year, the firm earned $1.42 EPS. On average, sell-side analysts forecast that Innospec Inc. will post 4.8 earnings per share for the current fiscal year.

Innospec Dividend Announcement

The business also recently announced a dividend, which will be paid on Friday, May 29th. Shareholders of record on Tuesday, May 19th will be given a dividend of $0.92 per share. This represents a dividend yield of 239.0%. The ex-dividend date is Tuesday, May 19th. Innospec’s payout ratio is presently 40.09%.

Insider Activity at Innospec

In other Innospec news, SVP David B. Jones sold 1,028 shares of the business’s stock in a transaction on Tuesday, March 3rd. The shares were sold at an average price of $75.64, for a total transaction of $77,757.92. Following the sale, the senior vice president directly owned 14,693 shares in the company, valued at approximately $1,111,378.52. The trade was a 6.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Larry Padfield sold 594 shares of the business’s stock in a transaction on Friday, February 27th. The stock was sold at an average price of $76.56, for a total transaction of $45,476.64. Following the sale, the director owned 9,453 shares in the company, valued at $723,721.68. The trade was a 5.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 4,989 shares of company stock valued at $391,889 over the last 90 days. Company insiders own 1.45% of the company’s stock.

Innospec Profile

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.